Regulation of aminopeptidase A in human brain tumor vasculature: Evidence for a role of transforming growth factor-β

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 973-980

  Juillerat Jeanneret, Lucienne ^a,c   Lohm, Sylvia ^a   Hamou, Marie France ^a   Pinet, Florence ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b l'alimentation et l'Environnement   (France)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; GLUTAMYL AMINOPEPTIDASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN TISSUE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0033946070     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780100     Document Type: Article

References (31)

1. Ardaillou R and Chansel D (1997). Synthesis and effects of active fragments of angiotensin II. Kidney Int 52:1458-1468.
2. Ariza A, Fernandez LA, Inagami T, Kim JH, and Manuelidis EE (1988). Renin in glioblastoma multiform and its role in neovascularization. Am J Clin Pathol 90:437-441.
3. Bull HG, Thornberry NA, and Cordes EH (1985). Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J Biol Chem 260: 2963-2972.
4. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, and Alhenc-Gelas F (1994). Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. J Biol Chem 269:26806-26814.
5. Darland DC and D'Amore PA (1999). Blood vessel maturation: Vascular development comes of age. J Clin Invest 103:157-158.
6. DeBault LE and Cancilla PA (1980). Gamma-glutamyltranspeptidase in isolated brain endothelial cells: Induction by glial cells in vitro. Science 207:653-655.
7. Diserens AC, de Tribollet N, Martin-Achard A, Gaide AC, Schnegg JF, and Carrel S (1981). Characterization of an established human malignant glioma cell line: LN-18. Acta Neuropathol (Berl) 53:21-28.
8. Fernandez LA, Twickler J, and Mead A (1985). Neovascularization produced by angiotensin II. J Lab Clin Med 105:141-145.
9. Fyhrquist F, Gronhagen-Riska C, Hortung L, Forslund T, and Tikkanen I (1983). Regulation of angiotensin converting enzyme. J Hypertens Suppl 1:25-30.
10. Galen FX, Devaux C, Atlas S, Guyenne TT, Ménard J, and Corvol P (1984). New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system. J Clin Invest 74:723-735.
11. Ganong WF (1993). Blood, pituitary, and brain reninangiotensin systems and regulation of secretion of anterior pituitary gland. Front Neuroendocrinol 14:233-249.
12. Goodfriend TL, Elliott ME, and Catt KJ (1996). Angiotensin receptors and their antagonists. N Engl J Med 334:1649-1654.
13. Herman K, Raizada MK, Sumners C, and Phillips MI (1987). Presence of renin in primary neuronal and glial cells from rat brain. Brain Res 437:205-213.
14. Joo F (1993). The blood-brain barrier in vitro: The second decade (Review). Neurochem Int 23:499-521.
15. Juillerat-Jeanneret L, Aguzzi A, Wiestler OD, Darekar P, and Janzer RC (1992). Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines. In Vitro Cell Dev Biol 28A: 537-543.
16. Juillerat-Jeanneret L (1993). Modulation of proteolytic activity in tissues following chronic inhibition of angiotensin converting enzyme. Biochem Pharmacol 45:1447-1454.
17. Kakinuma Y, Hama H, Sugiyama F, Yagami KI, Goto K, Murakami K, and Fukamizu A (1998). Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat Med 4:1078-1080.
18. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, and Struyker Boudier HA (1991). Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195:305-306.
19. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, and Robertson JW (1998). Do inhibitors of angiotensin converting enzyme protect against risk of cancer? Lancet 352:179-184.
20. Li D, Yang B, Philips MI, and Mehta JL (1999). Proapoptotic effects of Ang II in human coronary artery endothelial cells: Role of AT1 receptor and PKC activation. Am J Physiol 276:H786-H792.
21. Long DM, Hartmann JF, and French LA (1966). The response of human cerebral edema to glucosteroid administration. An electron microscopy study. Neurology 16:512-528.
22. Murata JI, Betz Corradin S, Felley-Bosco E, and Juillerat-Jeanneret L (1995). Involvement of a transforming-growth-factor-β-like molecule in tumor cell-derived inhibition of nitric oxide synthesis in cerebral endothelial cells. Int J Cancer 62:743-748.
23. Murata JI, Ricciardi-Castagnoli P, Dessous L'Eglise Mange P, Martin F, and Juillerat-Jeanneret L (1997). Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a γ-glutamyl transpeptidase assay. Int J Cancer 70:169-174.
24. Prontera C, Mariani B, Rossi C, Poggi A, and Rotilio D (1999). Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int J Cancer 81:761-766.
25. Reifenberger G, Bilzer T, Seitz RJ, and Wechsler W (1989). Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Acta Neuropathol (Berl) 78:270-282.
26. Seitz RJ, Dechert M, and Wechsler W (1988). Vascularization of syngenic intracerebral RG2 and F98 rat tranplantation tumors. A histochemical and morphometric study by use of ricinus communis agglutinin I. Acta Neuropathol (Berl) 76: 599-605.
27. Tontsch U and Bauer HC (1989). Isolation, characterization, and long-term cultivation of porcine and murine cerebral capillary endothelial cells. Microvasc Res 37:148-161.
28. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, and Bouck NP (1996). Captopril inhibits angiogenesis and slows the growth of experimental tumors. J Clin Invest 98:671-679.
29. Wolf G, Assmann KJM, and Stahl RAK (1997). Overexpression of aminopeptidase A abolishes the growth promoting effects of angiotensin II in cultured mouse mesangial cells. Kidney Int 52:1250-1260.
30. Zini S, Fournié-Zaluski MC, Chauvel E, Roques BP, Corvol P, and Llorens-Cortes C (1996). Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release. Proc Nat Acad Sci, USA 93:11968-11973.
31. Zini S, Masdehors P, Lenkei Z, Fournié-Zaluski MC, Roques BP, Corvol P, and Llorens-Cortes C (1997). Aminopeptidase A: Distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 78:1187-1193.